HtmlToText
-- -- -- -- -- challenge technology solutions partners press about us -- contact challenge technology solutions partners press -- about us contact our challenge how can we help to the ophthamologists to accelerate the screening of retinal diseases in order to detect disorders at their early stage? learn more our technology dreamup vision builds an innovative retinal analysis engine based on the state-of-the art machine learning known as deep learning . it performs a quick detection of complicated patterns in retinal images. learn more our solution our solutions is a saas platform which can be used by healthcare professionals staying in permanent contact with a diabetic patient. they facilitate early diagnosis of the different retinal disorders. learn more our challenge the total number of blind people is about 39 million, and of the visually impaired is approximately 285 million. the leading causes are cataract, glaucoma, macular degeneration, corneal opacities, diabetic retinopathy and eye conditions in children. the preventable causes of visual impairment are approximately 80% of the total cases. early diagnosis plays an invaluable role in such cases. diabetic retinopathy (dr) is the major cause for the blindness in the working-age population. diabetic retinopathy is caused by diabetes. statistically more than 75% of people who had diabetes for more than 20 years will have some form of dr. the early detection of dr could prevent blindness. the problem is that dr usually shows no symptoms before the later stages where the blindness cannot be avoided. the early diagnosis in the blood vessels of the retina can be made through regular retina monitoring. the regular retina analysis of diabetic patients is a worldwide problem, because nearly 3 million eyes will need to be evaluated by the ophthalmologists each day by 2030 (35 exams per second). another problem is the decrease of the number of ophthalmologists. we have a 54 % increase in the diabetes population against 2% growth in the number of ophthalmologists for 2030. besides, most people (80%) with diabetes live in low-income countries where the ophthalmologists are hardly accessible. in developed countries diabetic patients are supposed to visit an ophthalmologist each year, but in practice they do it even each 2-5 years which prevents early detection of the retina disorders. dreamup vision is aiming to help the healthcare professionals benefit from the latest advances in machine learning to create better retinal screening in order to detect the eye diseases at their early stage. . our technology these days we live in the era of artificial intelligence revolution via developments done in the field of deep learning algorithms. computers have learned to recognize objects in pictures, they learned to write like humans, they can drive cars, they are able to read emotions in our faces and in our voice, they are even able to dream and they have learned how to paint a-la van gogh. what is the difference between deep learning techniques and more traditional cognitive technologies? let's say we want to recognize different objects on an image. before the appearance of deep learning, a lot of feature engineering was needed in order to sum up the information contained in an image - or data in general - to simplify the decision process. indeed, the classic machine learning tools have difficulties to deal from complex data and human expertise is required to extract what is meaningful in the data, before feeding this preprocessed data to the algorithm. with deep learning on the other hand, the algorithm learns itself what is the best simplified representation of the data and what decision to take. deep learning techniques allows to outperform the more traditional methods in performance and to address issues that were not available to the machine before. -- our technologies are based on state-of-the art machine learning techniques, called deep learning. our algorithm achieves an area under the receiver operating characteristic curve auroc of 0.946 with 96.2% sensitivity (95% ci: 95.8–96.5) and 66.6% specificity (95% ci: 65.7–67.5) for identifying referable dr on the kaggle dataset. the performances we have obtained enable a reliable automated dr screening. as the amount of available labeled data grows and given our technology's ability to learn from labeled images, we believe that significant performance improvement can be achieved. the same process can be applied to the detection of other eye diseases as well. the results were published in acta ophthalmologica for the conference ever 2016, see the full abstract here . -- our solutions dreamup vision has developed a cognitive learning engine which relies on deep-learning technologies. this engine is a powerful tool in the image analysis and the detection of the disorders. our technology allows us detection of the stages of retinopathy with the performances of the professional ophthalmologists in milliseconds. this engine can be implemented both the online web-application as mobile application, or integrated directly into fundus camera. the retinal photo can be provided from any fundus camera. it can be analyzed online from any location, including from the retinopathy telemedicine centers existing in some countries. in these centers, the patients can take an appointment in order to have a retina photo taken by nurses or orthoptists. these photos are then sent to professional ophthalmologists in order to be analyzed. our solution could analyse the image directly at the center and thus to palliate to the leakage of ophthalmologists. mobile non-mydriatic fundus cameras allow today allow to take a high-quality photo of the eye fundus without pupil dilation. this kind of devices has numerous positive aspects. thus, the act of retinal scan becomes a simple medical act which can be done by other health professionals then ophthalmologists. we address to the health professionals which are most often in contact with diabetic patients, in other words: general practitioners, diabetologists, opticians, ophthalmologists, orthoptists, nurses etc. another aspect is the relatively low price of such a device which makes it accessible. the photo taken with such a device is then automatically analyzed by our artificial intelligence engine which detects the stage of the disease and then proposes a recommendation whether the patient should see an ophthalmologist, ot come back to make a screening. -- type saas platform and embedded solution linked to a visual recognition system able to distinguish the presence of a retinal abnormality on the basis of a fundus photo. goals screening diagnostics monitoring improvement of care targets general practitioners diabetologists opticians ophthalmologists orthoptists nurses type saas platform and embedded solution linked to a visual recognition system able to distinguish the presence of a retinal abnormality on the basis of a fundus photo. goals screening diagnostics monitoring improvement of care target general practitioners diabetologists opticians ophthalmologists orthoptists nurses -- our team ekaterina retinskaya-besse, phd former ceo, co-founder ekaterina is the former ceo and co-founder of dreamup vision. ekaterina has a phd degree in theoretical physics (2014). during her phd studies at the institut de physique théorique of the cea saclay, she was studying and developing theoretical models to describe the state of matter called quark-gluon plasma created in heavy-ion collisions at the lhc (cern, geneva) and rhic (bnl, brookhaven) colliders. after her phd, she joined dreamquark as chief operating officer and was developing deep learning algorithms. ekaterina became responsible for dreamup vision project in 2015 at dreamquark, and in 2016 has founded dreamup vision as an independent company. during her school career, in 2005 ekaterina won an international competition in mathematics and physics and was accepted into lomonosov moscow state university without examination with the highest score. during her studies in the physics department of lomonosov moscow state university, she won numerous prizes for the best students (rating top-10 among 450 students of the promotion) and graduated with the degree of masters in nuclear and particle physics, awarded with the "red" diploma issued to the best students of the promotion (2011). after her masters she has won a grant cfr of cea saclay, and moved to france to do her phd studies. at her free time, she plays piano (diploma with honours of 7-years music school), and practices sports and dancing. ekaterina is a former president of the r&d; commission (2015) and an actual administrator (2016) of france ehealthtech , association that unites startups in the sector of e-health and well-being in france. adrien besse, phd co-founder phd in theoretical physics, former student of ecole normale supérieure of lyon ("normalien"), m2 in theoretical physics of ens ulm, adrien is a co-founder of dreamup vision. with an experience of one year postdoctoral fellowship at the service of physique nucléaire of the cea saclay in 2013-2014 and the phd at the laboratoire de physique théorique of orsay (2013), his competences in theoretical physics as well as in mathematics are the necessary asset in the development of the artificial intelligence engine and of the statistical models. in 2014 adrien joined dreamquark as a chief research officer where he was responsible for research aspects of deep-learning algorithms, and in 2015 he became technical responsible for dreamup vision, where he plays a role of cto from 2016. adrien has several years experience in deep-learning field. adrien is passionate about sports, and is practicing "chistera" (national bask sport) in the national french leage of chistera. adrien is also playing classic and electric guitar. board members and advisors nicolas meric, phd co-founder, strategy advisor nicolas is the co-founder of dreamup vision and the founder of dreamquark. after finishing a phd in particle physics (2013) at cern (atlas experiment), cea saclay and lpthe, nicolas decided to apply what he has learned and developed during his phd studies to help insurance and healthcare companies to better use their data in order to provide better predictive models, prevention and diagnosis with the help of deep-learning algorithms and created dreamquark in march 2014. nicolas is advising dreamup vision on the business develoment. tram trinh, mba, cpa independent board director with 20-year international corporate experience in north america, europe and asia, tram is passionate about market creation. today tram helps digital health medtech start-ups or smes that want to expand in europe shape their strategy, land their ideal customers or their next strategic milestone. rapid results are achieved with her “door- opener” process. tram trinh founded vitanlink with one mission: instill hands-on & timely execution, grow and build out-of-the-box opportunities for/with the best people in the digital health medtech landscape. prior to vitanlink, she was instrumental in shaping new services within the medtech & diagnostics industry. at johnson&johnson; ocd, she took the responsibility of project leader france for the ceo office, then moved to market development director france and to europe middle east and africa head marketing services with 2 j&j; standards of leadership awards joining also the j&j; international "high-po" pool. in 2009, she was welch allyn general manager looking after the french speaking countries to create, expand, structure markets & teams including launching the company’s first connected vital signs devices in europe. prior to her healthcare journey, she co-structured in 1994 ernst&young; audit’s first business in vietnam & cambodia before joining the ey paris office. she also co-founded motion waves start-up. she had been a long time member of the cjd network of french entrepreneurs and teaching moderator at the cnam art et métiers innovation management program. tram is one of the founding executive members at avenir femmes santé, a french not-for-profit association for women’s health. she is also a mentor and advisory board member at key european, israeli and north american health startup accelerators and european patient associations. she holds an mba from mcgill university canada, an executive management certificate from columbia university and an american cpa license from new hampshire board of accounting, us. she is on the board of the ipel ivy plus european leaders international think tank and a nextgen member at amcham france. tram lives in paris and loves tai chi. dr. edouard colas chief medical officer ophthalmologist at the 15-20 ("quinze-vingts") french national ophtalmic center in paris, france. fellow of the european board of ophthalmology, he received the md degree from pierre et marie curie paris university in 2013. he is specialized in medical and surgical retinal diseases, trains ophthalmology residents and has participated in several books and scientific papers. he is also the ophtalmology expert of meltingdoc, the first app which connects french doctors and helps them solve complex medical cases. armen verdian, mba independent board member co-founder of ga partners, an independent m&a; firm, armen is also the co-founder of several start-ups, in particular cellprothera, a french biotech company specialized in heart regeneration through injection of autologous hematopoietic stem cells; and quintesens, a brand of innovative and organic nutritional food products. he is also an early investor and board member of dreamquark and wakie. axel orgogozo co-founder axel provides dreamup vision with his high-quality expertise on deep learning and computer vision expertise. axel has done his phd work at the laboratoire de physique theorique of the ecole normale superieure of paris in theoretical particle physics. his analytical and programming skills are an important asset to develop deep learning technics and to study innovative technologies. axel also develops 3d-graphics for computer games in his free time. collaborations, partnerships, accelerators dreamquark dreamup vision company is a spin-off of the company dreamquark (founded in 2014). dreamup vision has started as a project during a hackaton organised by novartis dedicated to the problems of diabetic patients in march 2015, and was officially registered as an independent company in june 2016. incubateur institut de la vision, paris incubator of institut of vision, based in paris, dedicated to innovative projects dedicated to the visual and auditory health. situated in the heart of quinze-vingts hospitals, institut of vision is one of the major research centers of the vision ilnesses in europe. eye focus accelerator, london and berlin eyefocus accelerator is the world's first innovation program for companies producing products for preventing, curing, and living with eye disease and blindness. accelerateur allianz an accelerator dedicated to big data, iot & wearables, fintecn and connected staduim. france ehealthtech ekaterina is an administrator of france ehealthtech. france ehealthtech is an association of french startups in ehealth and medtech. awards 100 startups to invest dreamup vision is presented as a project by company dreamquark, two companies are described together in the 100 startups to invest in france 2016. winner dreamup vision is a winner of startup pitch competition of differential medicine 2015 finalist dreamup vision is a top 8 finalist of sxsw international accelerator, we participated in sxsw finals in texas in march 2016. prix coup de coeur of the jury dreamup vision presented as a project by dreamquark in 2015, top-25 startups, prix coup de coeur du jury best startup and big data dreamup vision presented as a project by dreamquark in 2015, winner in 2 categories : best startup and big data prix airfrance for one of two best starups of french delegation by business france of web summit 2015. dreamup vision presented as a project by dreamquark in 2015. blogs to see our recent news and events, follow us on twitter! tweets from dreamup vision contact if your are interested in joining our company as: a partner: we are interested in the parthnerships and scientific advisory of healthcare professionals, hospitals and laboratories in order to face the challenge together. if you are interested in our solution, please contact us. an investor: if you want to invest in our company, we are looking for investors who share our values. any investor eager to participate to our endeavour will be warmly welcome. a team member: we are looking for bright, enthusiastic and highly-motivated individuals with a passion for complex challenges. if you feel you have the grit to join our team, then contact us. + 33 xxx xx xx xx -- contact@dreamupvision.com dreamupvision sas siret: 82098604000013 hq : 74 rue du faubourg saint antoine 75012 paris offices : 23 avenue d'italie, 75013 paris 2015 © dreamup vision. paris, france. all rights reserved.
Informations Whois
Whois est un protocole qui permet d'accéder aux informations d'enregistrement.Vous pouvez atteindre quand le site Web a été enregistré, quand il va expirer, quelles sont les coordonnées du site avec les informations suivantes. En un mot, il comprend ces informations;
Domain Name: DREAMUPVISION.COM
Registry Domain ID: 1952986653_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ovh.com
Registrar URL: http://www.ovh.com
Updated Date: 2017-07-07T13:58:02Z
Creation Date: 2015-08-14T12:41:11Z
Registry Expiry Date: 2018-08-14T12:41:11Z
Registrar: OVH
Registrar IANA ID: 433
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Name Server: DNS200.ANYCAST.ME
Name Server: NS200.ANYCAST.ME
DNSSEC: signedDelegation
DNSSEC DS Data: 54309 7 2 C25E339221E55925653B98EBCE1AE3531E4718F3C48F6D9B2132A12334AB96D6
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-06-11T23:27:24Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.
TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.
The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.
REGISTRAR OVH
SERVERS
SERVER com.whois-servers.net
ARGS domain =dreamupvision.com
PORT 43
TYPE domain
RegrInfo
DOMAIN
NAME dreamupvision.com
CHANGED 2017-07-07
CREATED 2015-08-14
STATUS
clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
NSERVER
DNS200.ANYCAST.ME 46.105.206.200
NS200.ANYCAST.ME 46.105.207.200
REGISTERED yes
Go to top
dreamupvision.com rapport :
Visitez le site